VC  Longitude Capital

https://www.longitudecapital.com/





     Office Locations:

2740 Sand Hill Road, 2nd Floor
Menlo Park, CA 94025
Phone: 650-854-5700

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Expansion
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Longitude Capital Management Co., LLC is a private equity and venture capital firm specializing in investments in all stages of development, from privately-held seed stage to publicly-traded later stage life sciences companies. The firm also invests in PIPEs. It primarily invests in the medical devices, biotechnology, specialty pharmaceuticals including drug-device combinations, and pharmaceutical development sectors. In medical devices, the firm has a preference for early stage companies, and in the case of the biotechnology sector, it prefers to invest in more mature companies. Longitude seeks to invest $10 million to $30 million over the life of each portfolio company, but its initial investment can be much smaller, particularly in early stage opportunities. It prefers to lead or co-lead its investments and requires a seat on the Board of Directors of its portfolio companies. Longitude Capital was founded in 2006 and is based in Menlo Park, California with an additional office in Greenwich, Connecticut. Since 2006, Longitude Capital has raised over $2 billion across six funds and demonstrated an ability to source, manage and exit attractive investments across multiple market cycles.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bethany Chen Associate
    Carolyn Helms Chief Financial Officer and Managing Director
    Juliet Bakker Managing Director
    Marc Galletti Managing Director
    Patrick Enright Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/23/2024


      Alpha-9 Oncology


      MA


      $175,000,000


      Series C


      09/06/2024


      OrsoBio


      CA


      $67,000,000


      Series B


      07/24/2024


      Kestra


      WA


      $196,000,000


      


      04/25/2024


      Endeavor BioMedicines


      CA


      $132,500,000


      Series C


      02/13/2024


      BioAge Labs


      CA


      $170,000,000


      Series D


      02/01/2024


      Cohere Health


      MA


      $50,000,000


      Venture


      01/03/2024


      Nalu Medical


      CA


      $65,000,000


      Series E


     

    Portfolio companies include:


      89Bio
        web link


      Alpha-9 Oncology
        web link


      ALPHAEON
        web link


      Amphora Medical
        web link


      Amunix
        web link


      Aptinyx


      AqueSys
        web link


      Avenge Bio
        web link


      Axonics Modulation Technologies
        web link


      BAROnova
        web link


      BioAge Labs
        web link


      Calhoun Vision
        web link


      CardioDx
        web link


      Ceribell


      CG Oncology
        web link


      Checkmate Pharmaceuticals
        web link


      Civitas Therapeutics
        web link


      Cohere Health
        web link


      Collegium Pharma
        web link


      Cortica
        web link


      CuraSen Therapeutics
        web link


      Cydan
        web link


      Eargo
        web link


      Endeavor BioMedicines
        web link


      Epirium Bio
        web link


      Esperion Therapeutics
        web link


      Inozyme Pharma
        web link


      Kala Pharmaceuticals
        web link


      Kestra
        web link


      Nalu Medical
        web link


      Orbus Therapeutics


      OrsoBio
        web link


      Poseida Therapeutics
        web link


      Practice Fusion
        web link


      Quanta Therapeutics
        web link


      Rapid Micro Biosystems
        web link


      Somatus


      SutroVax
        web link


      Sydnexis
        web link


      Talaris Therapeutics
        web link


      Theseus Pharmaceuticals
        web link


      Tiburio Therapeutics
        web link


      Tricida


      Velicept Therapeutics
        web link


      Vera Therapeutics
        web link


      Zavante Therapeutics
        web link


     

    Recent News: